These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18245395)
41. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117 [TBL] [Abstract][Full Text] [Related]
42. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Bai R; Napolitano C; Bloise R; Monteforte N; Priori SG Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):6-15. PubMed ID: 19808439 [TBL] [Abstract][Full Text] [Related]
43. The implications of genetic mutations in the sodium channel gene (SCN5A). Moric E; Herbert E; Trusz-Gluza M; Filipecki A; Mazurek U; Wilczok T Europace; 2003 Oct; 5(4):325-34. PubMed ID: 14753626 [TBL] [Abstract][Full Text] [Related]
44. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Benito B; Brugada R; Perich RM; Lizotte E; Cinca J; Mont L; Berruezo A; Tolosana JM; Freixa X; Brugada P; Brugada J Heart Rhythm; 2008 Oct; 5(10):1434-40. PubMed ID: 18929331 [TBL] [Abstract][Full Text] [Related]
45. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Pfeufer A; Sanna S; Arking DE; Müller M; Gateva V; Fuchsberger C; Ehret GB; Orrú M; Pattaro C; Köttgen A; Perz S; Usala G; Barbalic M; Li M; Pütz B; Scuteri A; Prineas RJ; Sinner MF; Gieger C; Najjar SS; Kao WH; Mühleisen TW; Dei M; Happle C; Möhlenkamp S; Crisponi L; Erbel R; Jöckel KH; Naitza S; Steinbeck G; Marroni F; Hicks AA; Lakatta E; Müller-Myhsok B; Pramstaller PP; Wichmann HE; Schlessinger D; Boerwinkle E; Meitinger T; Uda M; Coresh J; Kääb S; Abecasis GR; Chakravarti A Nat Genet; 2009 Apr; 41(4):407-14. PubMed ID: 19305409 [TBL] [Abstract][Full Text] [Related]
46. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation. Flaim SN; Giles WR; McCulloch AD Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201 [TBL] [Abstract][Full Text] [Related]
48. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study. Lehtinen AB; Daniel KR; Shah SA; Nelson MR; Ziegler JT; Freedman BI; Carr JJ; Herrington DM; Langefeld CD; Bowden DW Ann Noninvasive Electrocardiol; 2009 Jan; 14(1):72-9. PubMed ID: 19149796 [TBL] [Abstract][Full Text] [Related]
49. Long QT and Brugada syndrome gene mutations in New Zealand. Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336 [TBL] [Abstract][Full Text] [Related]
50. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients. Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727 [TBL] [Abstract][Full Text] [Related]
51. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family. Koo SH; Teo WS; Ching CK; Chan SH; Lee EJ Ann Acad Med Singap; 2007 Jun; 36(6):394-8. PubMed ID: 17597962 [TBL] [Abstract][Full Text] [Related]
52. In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant. Lin MT; Wu MH; Chang CC; Chiu SN; Thériault O; Huang H; Christé G; Ficker E; Chahine M Heart Rhythm; 2008 Nov; 5(11):1567-74. PubMed ID: 18848812 [TBL] [Abstract][Full Text] [Related]
53. Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation. Zareba W; Sattari MN; Rosero S; Couderc JP; Moss AJ Am J Cardiol; 2001 Dec; 88(11):1311-4. PubMed ID: 11728364 [No Abstract] [Full Text] [Related]
54. Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation. Tester DJ; Valdivia C; Harris-Kerr C; Alders M; Salisbury BA; Wilde AA; Makielski JC; Ackerman MJ Heart Rhythm; 2010 Jul; 7(7):912-9. PubMed ID: 20403459 [TBL] [Abstract][Full Text] [Related]
55. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Ueda K; Valdivia C; Medeiros-Domingo A; Tester DJ; Vatta M; Farrugia G; Ackerman MJ; Makielski JC Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9355-60. PubMed ID: 18591664 [TBL] [Abstract][Full Text] [Related]
56. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction. Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221 [TBL] [Abstract][Full Text] [Related]
57. 25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. Moss AJ; Schwartz PJ Circulation; 2005 Mar; 111(9):1199-201. PubMed ID: 15753228 [No Abstract] [Full Text] [Related]
58. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Aurlien D; Leren TP; Taubøll E; Gjerstad L Seizure; 2009 Mar; 18(2):158-60. PubMed ID: 18752973 [TBL] [Abstract][Full Text] [Related]